Q1 2022 Holdings
Filed 2022-05-13 | 17 holdings | $48.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $21.7M | 1,258,243 | 45.2% |
| Cullinan Oncology, Inc.(CGEM) | COM | 230031106 | $10.4M | 992,507 | 21.6% |
| Adagio Therapeutics, Inc.(IVVD) | COM | 00534A102 | $6.5M | 1,431,826 | 13.6% |
| Compass Therapeutics, Inc.(CMPX) | COM | 20454B104 | $6.0M | 4,400,000 | 12.6% |
| Cue Health Inc.(HLTHQ) | COM | 229790100 | $3.2M | 490,546 | 6.6% |
| Pardes Biosciences Inc | COM | 69945Q105 | $67.9K | 9,400,515 | 0.1% |
| Theseus Pharmaceuticals, Inc. | COM | 88369M101 | $37.0K | 3,212,732 | 0.1% |
| Somalogic, Inc.(SLGCUSD) | COM CL A | 83444K105 | $29.9K | 3,726,472 | 0.1% |
| Hims & Hers Health, Inc.(HIMS) | COM CL A | 433000106 | $14.4K | 2,706,922 | 0.0% |
| Adicet Bio, Inc.(TORCEUR) | COM | 007002108 | $13.6K | 680,000 | 0.0% |
| Quantum-Si Incorporated(QSI) | COM CL A | 74765K105 | $11.0K | 2,342,061 | 0.0% |
| Kinnate Biopharma Inc. | COM | 49705R105 | $9.9K | 875,001 | 0.0% |
| Research Alliance Corp. II | COM CL A | 760873109 | $4.9K | 500,000 | 0.0% |
| Gemini Therapeutics, Inc. | COM | 36870G105 | $3.4K | 2,435,125 | 0.0% |
| Enanta Pharmaceuticals, Inc.(ENTA) | COM | 29251M106 | $3.0K | 42,250 | 0.0% |
| 23andMe Holding Co. | COM CL A | 90138Q108 | $1.6K | 406,913 | 0.0% |
| Pharvaris N.V.(PHVS) | COM | N69605108 | $619 | 34,142 | 0.0% |